洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR-INR-16010047】針刺聯合穴位敷貼治療鼻鼽(過敏性鼻炎症狀)的隨機對照臨床試驗

基本信息
登记号

ChiCTR-INR-16010047

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2016-11-25

临床申请受理号

/

靶点

/

适应症

鼻鼽(過敏性鼻炎症狀)

试验通俗题目

針刺聯合穴位敷貼治療鼻鼽(過敏性鼻炎症狀)的隨機對照臨床試驗

试验专业题目

針刺聯合穴位敷貼治療鼻鼽(過敏性鼻炎症狀)的隨機對照臨床試驗

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

To determine the clinical effectiveness of either acupuncture combined with herbal moxibustion or acupuncture alone when compared to waiting list for patients with allergic rhinitis symptoms, measured by the improvement of nasal condition, quality of life, and serum IgE level.

试验分类
试验类型

随机平行对照

试验分期

治疗新技术

随机化

Randomized

盲法

Single-blind on Investigator/research team

试验项目经费来源

NA

试验范围

/

目标入组人数

0;48

实际入组人数

/

第一例入组时间

1990-01-01

试验终止时间

1990-01-01

是否属于一致性

/

入选标准

1. Medical history: the subject has a history of allergic rhinitis, which is related to change in temperature and allergens such as pollen, dust mites, etc; 2. Clinical symptoms: the subject has the primary symptoms of nasal congestion, runny nose, sneezing and nasal itchiness. Subjects must have two or more of these symptoms; 3. Aged between 18 - 65; 4. A Total Nasal Symptom Score (TNSS) ≥ 4; 5. The subject agrees to take part in this study and is fully capacitated, can express personal will and accurately describe symptoms.;

排除标准

1. Has undertaken Chinese medicine treatment related to allergic rhinitis over the past month; 2. Has contracted respiratory infection or acute paranasal sinusitis within the past 14 days; 3. Has a history of chronic paranasal sinusitis; 4. Has organic nasal pathological changes or has had nasal surgeries; 5. Has asthma and other respiratory attack conditions; 6. Has taken antihistamines, steroids, decongestants (used on the nose, the mouth and the eyes), antibiotics, anti-coagulant and anti-platelet agents in the past month; 7. Has undertaken specific immune treatment or systemic hormone therapy in the past year; 8. Has serious cardiac, liver, renal, cerebrovascular conditions, or neural or mental disorders, etc.; 9. Be pregnant or nursing, or planning to conceive during the course of treatment; 10. Has G6PD; 11. Has wounds at the punctured locations or diabetes mellitus.;

研究者信息
研究负责人姓名
试验机构

Department of Chinese Medicine, Hospital Authority

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

Department of Chinese Medicine, Hospital Authority的其他临床试验

Nethersole Chinese Medicine Service cum The Chinese University of Hong Kong Chinese Medicine Clinical Training and Research Centre的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品